Related Experiment Videos
Clinical trials of agents that reverse multidrug-resistance
1National Cancer Institute Bethesda, MD.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.
The Journal of biological chemistry·1992
Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
The Journal of biological chemistry·1992
Transfer and expression of the human multiple drug resistance gene into live mice.
Proceedings of the National Academy of Sciences of the United States of America·1992
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026